Constipation and associated intervention in patients with overactive bladder treated with darifenacin or tolterodine
Thomas S1, Romanzi L2, Lheritier K 3 1. Encino-Tarzana Medical Center, CA, USA, 2. New York Presbyterian Hospital, NY, USA, 3. Novartis Pharma AG, Basel, Switzerland
|
|
Abstract 150
|
|
|
Non Discussion Posters
Scientific Non Discussion Poster Session 17
|
|
|